Twenty normal canine tissue specimens, both fetal and adult; 19 epithelial neoplasms; and 18 nonepithelial neoplasms were examined using 6 commercially available monoclonal antibodies differing in their recognition of various molecular weight cytokeratins in human tissues. Fresh tissue samples were fixed in 100% ethanol and paraffin embedded prior to sectioning. The intermediate filament proteins were identified by an avidin-biotin-immunoperoxidase method. Primary antisera used included AE1/AE3, CAM-5.2, 35BH11, 34BE12, PKKl, MAK-6 cytokeratins, and vimentin. Monoclonal antibodies detected cytokeratins in a wide variety of canine epithelial tissues and neoplasms. Normal mesenchymal tissues and neoplasms, and stromal elements of epithelial tissues, showed no reactivity with anti-cytokeratins, but reacted positively with vimentin. Although PKKl, CAM-5.2, and MAK-6 were the most consistently reactive anti-cytokeratins, the full panel of monoclonals was required to detect cytokeratins in all of the epithelia evaluated.
Immunohistochemical methods using antibodies directed to the intermediate filament proteins of the cytoskeleton are useful in the diagnostic laboratory for discriminating between the broad categories of sarcoma and carcinoma. A variety of antibodies for subdividing the various cytokeratin proteins are now available. 7,1l There are more than 19 subclasses of cytokeratins identified on the basis of molecular weights, charge specificities, and immunoreactivities with monoclonal antibodies possessing restricted specificities l0,1l Characterization of the particular subclass of cytokeratin intermediate filaments has the clinical utility of being able to distinguish poorly differentiated epithelial malignancies from nonepithelial malignancies, particularly the lymphomas and melanomas, but also from other undifferentiated sarcomas. Further characterization of the intermediate filaments of the cytoskeleton offers information regarding the degree of differentiation of the neoplasm, thus assisting in tumor grading, which may have value regarding treatment and prognosis? There have been several studies noting the clinical use of cytokeratin antibodies for detection of intermediate filament proteins in canine tissues l,4,l0,l2 In the present study, we have utilized alcohol-fixed tissues and an expanded repertoire of commercially available cytokeratin monoclonal antibodies to immunohistochemically characterize normal epithelial structures and epithelial-derived neoplasms of the dog. The aim of the study was to provide record of the antibodies with the greatest sensitivity for recognition of the cytokeratin components of the cytoskeleton in alcohol-fixed canine specimens.
Materials and methods
Tissues. The primary tissues studied were collected from dogs at the time of surgical procedures or necropsy examinations and represented both normal and neoplastic tissues derived from epithelium as well as mesenchyme. The normal tissues were collected from healthy adult dogs, as well as from a canine fetus of 6 weeks gestation. The tissues studied are listed in Tables l-3. Freshly collected tissues were fixed immediately in 100% ethanol and routinely processed to paraffin. Histologic sections of each tissue were stained with hematoxylin and eosin (HE) for microscopic examination. The sections were used to confirm a diagnosis, as well as enabling representative areas of each specimen to be selected for immunohistochemical study. Selected regions were marked on the HE slides using a wax pencil and matched to the original paraffin-embedded tissue blocks. The selected regions were then cored out of the paraffin blocks using a modified 12-gauge stainless steel needle with a straight beveled edge.
The tissue cores were arranged in parallel fashion, and paraffin-processed pork sausage casing a was then wrapped tightly around the tissue cores, forming a "tissue sausage." The entire sausage was then paraffin-embedded, and histologic slides were prepared of its cross section ( Fig. 1 ). One slide from each "sausage" was stained with HE and examined microscopically to determine the location of each tissue core on the slide. This "map" then served as a guide for subsequent evaluations. This method was adapted from a previously described procedure. 3 Antibodies. Six different human monoclonal antibodies to cytokeratin proteins were examined in the present study. The monoclonal antibodies were obtained commercially and included AEl/AE3, b CAM-5.2, c MAK-6, d PKKl, e 35BHll, f and 34BEl2. f AEl/AE3 is a combination antibody that is reported to recognize low molecular weight acidic human proteins in the range of 50-56.5 kD, and higher molecular weight, primarily basic keratins in the range of 58, and 65-67 kD. CAM-5.2 is reported to recognize human cytokeratins of molecular weights 39, 43, and 50 kD. MAK-6 is a combination antibody recognizing cytokeratins of molecular weights ranging from 40 to 52.5 kD. PKKl is reported to react with cytokeratin polypeptides of 40, 45, and 52.5 kD. Antibody 35BH11 is a low molecular weight anti-cytokeratin, recognizing cytokeratin proteins of 52.5 kD, and 34BE12 recognizes high molecular weight cytokeratins of 56, 56.5, and 58 kD. Information regarding antibody specificities was obtained from package inserts provided by the manufacturers.
Immunohistochemistry. A standard avidin-biotin-peroxidase complex method 9 was used. Optimum working dilutions in phosphate-buffered saline (PBS) were determined by a 2-fold dilution series tested against normal canine skin and intestine using the immunoperoxidase method described below. The dilutions used were CAM-5.2 (undiluted), AE1/ AE3 (1:200), 35BHll (1:400 and 1:4,000), 34BE12 (1:5,000), PKKl(l:50 and 1:l00), and MAK-6 (1: 10). When 2 dilutions were used it was because different lots of the same antibody had differing optimum working dilutions. An anti-vimentin antibody g (1: 100) was used as a postive control for mesenchymal tissues. For a negative control, PBS was used in place of the primary antisera. Following reconstitution, the primary antibodies were stored at 4 C. Three-micron sections of "sausage" were deparaffinized in toluene followed by 2 ethanol baths (Fig. 2) . The tissues were blocked with 0.3% hydrogen peroxide in methanol for 30 min and rinsed in PBS buffer. Nonspecific staining was blocked with 10% normal horse serum h and incubated for 20 min at room temperature. The primary antisera and negative control PBS were applied to the sections and incubated for 1 hr. Following this incubation and each subsequent step slides were rinsed in 2 changes of PBS buffer for 5 min each. The linking agent, biotinylated horse anti-mouse antibody, h was applied to all slides for 30 min followed by the avidin-biotinhorseradish peroxidase for 20 min. Incubations during the procedure were carried out at room temperature in a humidified chamber.
Antibody localization was determined with the use of 3,3diaminobenzidine (DAB) i in imidazole buffer. The slides were counterstained with Mayer's hematoxylin, washed in tap water, dehydrated to xylene, and coverslipped.
Each slide was examined microscopically for evidence of reactivity of the primary antisera. A score of + + + was used to indicate strong reactivity, + + for moderate reactivity, + for weak reactivity, and negative for no reactivity.
IMMUNOHISTOCHEMICAL STAINING METHOD

Results
The results of the immunohistochemical studies for detection of cytokeratin intermediate filaments in normal canine tissues are given in Table 1 . Seventeen tissues collected from healthy adult dogs and 12 tissue sections from a canine fetus served as prototypal controls. No mesenchymal structures in any of the adult or fetal nonepithelial tissues studied, or in stromal elements of the epithelial tissues examined, reacted for any of the cytokeratin antibodies evaluated, although these components reacted strongly for vimentin in both fetal and adult tissues.
The epithelial linings of the gastrointestinal tract, the transitional epithelium of the urinary bladder, renal tubular epithelium, and the columnar bronchial epithelium showed various degrees of reactivity with the cytokeratin antibodies studied. The strongest reactivity was seen with CAM-5.2, PKKI, and MAK-6 in pancreatic acini, pancreatic ductal epithelium, adult and fetal bile duct epithelium, and gallbladder columnar epithelium. Adult hepatic cells were nonreactive with all the antibodies; however, in the fetal hepatic cells, moderate reactivity was observed using PKKl and weak reactivity with CAM-5.2, 35BHl1, and MAK-6. The mucosal linings of the esophagus, stom-ach, duodenum, jejunum, colon, and rectum showed moderate to strong reactivity with all of the antibodies except 35BH11 and 34BE12. Adult renal tubular epithelium was strongly reactive with CAM-5.2 and PKKl and moderately reactive with MAK-6, whereas fetal renal tubular epithelium was moderately reactive with CAM-5 and strongly reactive with PKKl and MAK-6. Pulmonary alveolar epithelial cells were nonreactive with any of the antibodies, although bronchiolar epithelium reacted strongly with all of the antibodies except 35BH11 and 34BE12. Fetal bronchiolar epithelium showed slightly less reactivity.
Adult epidermis reacted with all 6 anti-cytokeratins. Four components of adult canine epidermis were separately evaluated, including the basalar and suprabasalar epithelia, sweat gland ducts, and follicular epithelium. Basalar and suprabasalar epithelia were uniformly nonreactive to any of the anti-cytokeratins. In contrast, sweat gland ducts reacted strongly with CAM-5.2, PKKl, MAK-6, and 34BE12 and only moderately with AE1/AE3. Hair follicular epithelium was strongly reactive with 34BE12 and moderately reactive with PKKl, MAK-6, and AEl/AE3. Interestingly, fetal skin showed a different pattern of reactivity in that basalar epithelium and hair follicular epithelium were markedly reactive with 34BEI2 and moderately reactive with PKK1. Fetal suprabasalar epthe corresponding adult tissue, with the exceptions of ithelium was strongly reactive with 34BE12 and modliver and epidermis noted above. Fetal adrenal, brain, erately reactive with MAK-6 and PKK1. Sweat gland and thymus were nonreactive for all of the cytokeratin ducts were not identified in fetal epidermis. antibodies studied. The reactivity of fetal tissues to each of the primary The results of the immunohistochemical studies for antibodies was similar but slightly less, in general, to cytokeratin intermediate filament proteins in neoplas- 
Vimentin and PBS were used as positive mesenchymal and negative controls, respectively. Reactivity was judged as strong (+ + +), moderate (+ +), weak (+), or negative (-), respectively. * Stromal elements. † NS, none shown. 
Vimentin and PBS were used as positive mesenchymal and negative controls, respectively. Reactivity was judged as strong (+ + +), moderate (+ +), weak (+), or negative (-), respectively. * Stromal elements. † NS, none shown. tic canine nonepithelial tissues are shown in Table 2 . Eighteen nonepithelial tissues were examined; all showed reactivity for' vimentin and were uniformly negative for the cytokeratins studied.
The greatest variations in reactivity of any tissue to the different cytokeratin antibodies were within the group of epithelial neoplasms evaluated (Table 3) . There were 8 different mammary neoplasms examined; all of the cytokeratin antibodies, with the exception of 35BH11, reacted moderately or strongly with the carcinomas, cystadenomas, or epithelial components of the mixed mammary tumors. Similarly, 2 lung tumor specimens were reactive with most of the antibodies studied, although 35BHll and 34BEl2 reacted positively with only 1 of the 2 tumors.
A transitional cell carcinoma derived from the urinary bladder was moderately reactive with CAM-5.2 and PKKl and only weakly reactive with MAK-6 and AE1/AE3. A rectal carcinoma showed strong reactivity to all cytokeratin antibodies except AEl/AE3 and 35BH11. A pancreatic islet cell carcinoma was weakly reactive only with 35BH11. A prostatic squamous cell carcinoma and a dermal squamous cell carcinoma each showed positive reactions for cytokeratins with 5 of the 6 antibodies. An acanthomatous epulis reacted with 5 of the 6 cytokeratin antibodies.
The 3 circumanal adenomas were generally poorly reactive for anti-cytokeratins, with the exception of strong reactivity shown by all 3 specimens with 34BE12. The reactivity of 1 of the circumanal adenomas with the 6 anti-cytokeratins is illustrated (Fig. 3) .
Discussion
The results of this study provide further evidence for the utility of several commercially available monoclonal antibodies for detection of cytoskeletal intermediate filament proteins in alcohol-fixed, normal, and neoplastic canine tissues using routine avidin-biotinperoxidase immunohistochemical methods.
It has been shown that most human epithelial tissues elaborate cytokeratins with molecular weights of 40, 46, and 52 kD. 2 One would predict that antibodies AEl/AE3, MAK-6, or PKKl might be used as a general screen to detect the presence of cytokeratins because these react with cytokeratins of this range. We found that CAM-5.2, PKKl, and MAK-6 reacted most often and most intensely with the canine epithelial tissues studied, although some tissues reacted only weakly or not at all. The full panel of 6 antibodies was required to detect cytokeratin intermediate filament proteins in all of the epithelial tissues studied.
The weakest reacting antibody in the panel of 6 anticytokeratins used in this study proved to be 35BHll. The manufacturer's insert suggests that alcohol-fixed tissues give better results than formalin-fixed tissues. This study, however, which utilized only alcohol-fixed specimens, showed very low overall reactivity of this antibody with epithelial tissues derived from the dog. Only 2 specimens reacted strongly, and 2 showed moderate reactivity; the remaining tissues reacted weakly or negatively with 35BH11.
Human cytokeratins 8 and 18 are expressed early during embryogenesis and correspond to anti-cytokeratins MAK-6, PKKl, and 35BHll. 11 In this study, canine fetal epithelia were indeed most responsive to CAM-5.2, PKKl, and MAK-6. Antibody 35BH11 generally showed negative to moderate reactivity, which was a consistent finding throughout this study. Although fetal tissues showed similar patterns of anti-cytokeratin reactivity to their adult tissue counterparts, fetal specimens were generally less reactive to the anti-cytokeratins, suggesting that as development proceeds, epithelial cells elaborate greater cytokeratin expression.
There were 2 examples of fetal specimens showing a markedly different pattern of cytokeratin expression from that of the corresponding adult tissues. Whereas adult basalar and suprabasalar epithelia were nonreactive with any of the anti-cytokeratins, fetal basalar epithelium reacted moderately to strongly with 2 of the 6 anti-cytokeratin antibodies, and fetal suprabasalar epithelium reacted moderately to strongly with 3 of the 6. Similarly, whereas adult hepatic cells showed negative reactivity with all 6 anti-cytokeratins, fetal hepatic cells reacted weakly with 3 of the 6 anti-cytokeratins. In general, as embryogenesis proceeds, low molecular weight cytokeratins in epithelia will be replaced with cytokeratins of higher molecular weight. 2, 14 This pattern of maturation was not consistently demonstrated in the present study, however, which may reflect at least in part differences in canine cytokeratin proteins from those to which the antibodies used were designed.
Human bronchiolar epithelium, bladder epithelium, and simple epithelium of the gastrointestinal tract and its associated structures (liver, gallbladder, intestine) elaborate cytokeratins 7, 8, 18, and 19, ll corresponding to reactivity with all anti-cytokeratins used in this study except 34BE12 and AE1/AE3. Normal adult bronchial epithelium reacted moderately to strongly with all antibodies except 35BH11, to which it was weakly reactive. Fetal bronchiolar epithelium was less reactive, and showed no reaction with 35BH1l. Two pulmonary neoplasms showed strong reactivity to CAM-5.2, PKKl, and MAK-6, and moderate to no reactivity to the other anti-cytokeratins evaluated.
Normal canine adult bladder epithelium was strongly reactive to all antibodies except 35BH11, with which it was weakly reactive. Human renal and urinary bladder transitional cell carcinomas have shown strong reactivity to 34BE12 and 35BH11 . 8 A transitional cell carcinoma evaluated in this study was generally nonreactive to the anti-cytokeratins evaluated, except for moderate reactivity with PKKl and CAM-5.2. Tumor tissue derived from renal components was not available during this study to test reactivity with the cytokeratin antibodies. Normal adult and fetal gastrointestinal tract speci-mens were generally moderately to strongly reactive to most of the anti-cytokeratins, with variable reactivity to 35BHll and 34BE12.
Neoplastic pancreatic tissues were poorly reactive to anti-cytokeratins; 35BH11 was the only antibody to show weak reactivity. In contrast, normal pancreatic acini and ductal epithelium reacted strongly with CAM-5.2, PKKl, and MAK-6. Islets of Langerhans were nonreactive with anti-cytokeratin antibodies except for 35BH11, for which they were weakly reactive.
The human epidermis and pilosebaceous tracts have been shown to express basic, high molecular weight cytokeratins, including 1-2, 5-6, and 9-11, as well as an acidic group, 14-l7.ll These cytokeratins correlate with reactivity to antibodies AEl/AE3, 34BE12, and MAK-6. These antibodies reacted positively with both adult and fetal canine specimens. We also noted reactivity by the other 4 anti-cytokeratins with adult epidermal tissue. CAM-5.2 and 35BH11 were negative in fetal epidermis.
Human squamous cell carcinomas tended to be strongly reactive with 34BE12 and poorly reactive with 35BHll in 1 study. 8 Other studies, however, have revealed unique patterns of distribution or expression of the cytokeratins in individual squamous cell carcinomas and in adamantinomas. l0 Indeed, the canine prostatic squamous cell carcinoma showed a markedly different pattern of anti-cytokeratin reactivity than did the canine preputial squamous cell carcinoma and acanthomatous epulis. Ultimately, the various patterns of cytokeratin reactivity of tissues to different antibodies will be exploited by the diagnostic pathologist to discriminate various grades of malignancy or, indeed, to distinguish between neoplastic or metaplastic lesions. l4 Eight mammary neoplasms were evaluated for anticytokeratin reactivity in this study. Mammary epithelia generally elaborate cytokeratins 4-6, ll corresponding to anti-cytokeratins AE1/AE3 and 34BE12. Additionally, complex glands often contain cytokeratins 7 and 9, which would include the other 4 cytokeratin antibodies used in this study. Indeed, 2 papillary adenocarcinomas reacted strongly to all anticytokeratins except 35BH11. Two adenocarcinomas and 2 papillary cystadenomas showed similar reactivity. The epithelial component of 2 mixed mammary tumors showed strong reactivity to CAM-5.2, 34BE12, PKKl, and MAK-6 and moderate reactivity to AE1/ AE3. The myoepithelial components were nonreactive with all the anti-cytokeratins studied, but expressed vimentin. The mixed mammary tumors generally showed more intense staining for neoplastic cells than the adjacent normal mammary glandular epithelium.
A human synovial cell sarcoma has shown focal reactivity with 35BHll and 34BE12, as well as with vimentin. 8 In this study, only vimentin evoked posi-tive reactivity, duplicating the results of previous work involving this canine neoplasm. l2 As that author noted, the canine epithelial component in synovial cell sarcomas may not be as pronounced as that of its human counterpart, although a larger series of canine synovial cell sarcomas needs to be studied to define precisely the intermediate filament content of this neoplasm.
Mesenchymal tissues and their neoplasms, and stromal elements of epithelial tissues, were all nonreactive with any of the anti-cytokeratin antibodies and, as expected, reacted positively with vimentin.
Until recently, the cytokeratin proteins were identified in tissues using polyvalent antiserums. Using those reagents, virtually all of the epithelia were positive and no discrimination among epithelial tumors could be made because most antisera contained antibodies against most cytokeratin antigenic determinants. l5 The development of monoclonal antibodies against specific cytokeratins has now allowed distinctions to be made within the categories of epithelial tissues and their tumors, and data are being generated to show the utility of specific cytokeratins in determining the differentiation of normal epithelial cells and establishment of the origin of metastases of poorly differentiated tumors. l5 The fact that primary epithelial tumors, their metastases, as well has cultured cell lines tend to retain characteristic patterns of cytokeratin expression offers new insights into the characterization of neoplasms. l3 It is also known, however, that some tumors express complex patterns of cytokeratins that are absent from or express only a minor component of the tissue of origin; histogenetic mechanisms that regulate the expression of these diverse proteins are unknown. 6 The results obtained using immunohistochemical methods for detection of cytokeratin protein expression in chemically fixed tissues must be viewed with careful scrutiny. Although positive results may be obtained with tissues stored in a variety of fixatives, it is clear that the most precise spectrum of intermediate filament expression is currently attained when frozen material is used. 7 All tissues examined in this study were fixed immediately in absolute alcohol after procurement; alcohol fixation appears to be superior to formalin fixation. 12, 13 It is prudent, perhaps, to fix fresh samples in several fixatives to permit analysis of a wide variety of antigens and to circumvent the need for additional biopsies or surgical procedures. 7
